BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 33379862)

  • 1. Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development.
    Hou L; Rong J; Haider A; Ogasawara D; Varlow C; Schafroth MA; Mu L; Gan J; Xu H; Fowler CJ; Zhang MR; Vasdev N; Ametamey S; Cravatt BF; Wang L; Liang SH
    J Med Chem; 2021 Jan; 64(1):123-149. PubMed ID: 33379862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classics in Neuroimaging: Imaging the Endocannabinoid Pathway with PET.
    Varlow C; Boileau I; Wey HY; Liang SH; Vasdev N
    ACS Chem Neurosci; 2020 Jul; 11(13):1855-1862. PubMed ID: 32559067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
    Petrosino S; Di Marzo V
    Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system's involvement in motor development relies on cannabinoid receptors, TRP channels, and Sonic Hedgehog signaling.
    Khara LS; Ali DW
    Physiol Rep; 2023 Jan; 11(1):e15565. PubMed ID: 36636759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s).
    Suzuki H; Ito Y; Noro Y; Koketsu M; Kamijima M; Tomizawa M
    Toxicol Lett; 2014 Feb; 225(1):153-7. PubMed ID: 24361246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity.
    Zhang L; Butler CR; Maresca KP; Takano A; Nag S; Jia Z; Arakawa R; Piro JR; Samad T; Smith DL; Nason DM; O'Neil S; McAllister L; Schildknegt K; Trapa P; McCarthy TJ; Villalobos A; Halldin C
    J Med Chem; 2019 Sep; 62(18):8532-8543. PubMed ID: 31483137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.
    Wilson AA; Garcia A; Parkes J; Houle S; Tong J; Vasdev N
    Nucl Med Biol; 2011 Feb; 38(2):247-53. PubMed ID: 21315280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
    Hicks JW; Parkes J; Sadovski O; Tong J; Houle S; Vasdev N; Wilson AA
    Nucl Med Biol; 2013 Aug; 40(6):740-6. PubMed ID: 23731552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.
    Chicca A; Arena C; Manera C
    Recent Pat CNS Drug Discov; 2016; 10(2):122-141. PubMed ID: 27630088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers.
    Postnov A; Schmidt ME; Pemberton DJ; de Hoon J; van Hecken A; van den Boer M; Zannikos P; van der Ark P; Palmer JA; Rassnick S; Celen S; Bormans G; van Laere K
    Clin Transl Sci; 2018 Jul; 11(4):397-404. PubMed ID: 29575526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocannabinoid system: current pharmacological research and therapeutic possibilities.
    Jonsson KO; Holt S; Fowler CJ
    Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):124-34. PubMed ID: 16445584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.
    Della Pietra A; Giniatullin R; Savinainen JR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
    Pertwee RG
    Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.
    Paredes-Ruiz KJ; Chavira-Ramos K; Orozco-Morales M; Karasu C; Tinkov AA; Aschner M; Santamaría A; Colín-González AL
    Neurotox Res; 2021 Dec; 39(6):2072-2097. PubMed ID: 34741755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
    Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
    Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain using Positron Emission Tomography Tracer [
    Yamasaki T; Ohya T; Mori W; Zhang Y; Wakizaka H; Nengaki N; Fujinaga M; Kikuchi T; Zhang MR
    J Pharmacol Exp Ther; 2020 Jun; 373(3):353-360. PubMed ID: 32241809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid system alterations in Alzheimer's disease: A systematic review of human studies.
    Berry AJ; Zubko O; Reeves SJ; Howard RJ
    Brain Res; 2020 Dec; 1749():147135. PubMed ID: 32980333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors.
    Niphakis MJ; Johnson DS; Ballard TE; Stiff C; Cravatt BF
    ACS Chem Neurosci; 2012 May; 3(5):418-26. PubMed ID: 22860211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel monoacylglycerol lipase-targeted
    Cheng R; Fujinaga M; Yang J; Rong J; Haider A; Ogasawara D; Van RS; Shao T; Chen Z; Zhang X; Calderon Leon ER; Zhang Y; Mori W; Kumata K; Yamasaki T; Xie L; Sun S; Wang L; Ran C; Shao Y; Cravatt B; Josephson L; Zhang MR; Liang SH
    Acta Pharmacol Sin; 2022 Nov; 43(11):3002-3010. PubMed ID: 35513432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.